{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:44:23Z","timestamp":1793133863244,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lupus nephritis remains a severe manifestation of systemic lupus erythematosus across African populations, where diagnostic and therapeutic challenges significantly impact patient outcomes. This systematic review examines the clinical spectrum and management realities of this condition in African settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Following PRISMA guidelines, we identified seven qualifying studies after screening 662 records from major databases. The analysis included five case reports and two case series documenting confirmed lupus nephritis cases across multiple African regions. We systematically evaluated patient characteristics, diagnostic approaches, treatment regimens, and clinical outcomes using standardized quality assessment tools.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Seven studies reporting 16 patients from four countries were included. The female-to-male ratio was 14:2 (7:1). Histological classifications included Class IV (5 cases), Class V (4 cases), Class VI (3 cases), and mixed IV\/V (1 case), with one case diagnosed clinically. Two patients died and three progressed to end-stage renal disease requiring dialysis. Most cases occurred in young women, commonly presenting with nephrotic syndrome and hypertension. Proliferative and membranous patterns were the predominant biopsy findings. Corticosteroid-based regimens led to improvement in several patients, though outcomes varied regionally, with North African cases showing better responses than those from other regions where late presentation predicted poorer prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These findings underscore both the clinical challenges and opportunities in managing lupus nephritis across Africa. The demonstrated variability in outcomes calls for coordinated efforts to establish context-appropriate diagnostic protocols and treatment guidelines, with particular attention to resource-limited settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trials<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04502-8","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:18:32Z","timestamp":1759843112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lupus nephritis in Africa: a systematic review of case reports and case series"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohamed","family":"Jayte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdifitah Abdullahi","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdifatah","family":"Karshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awil Abdulkadir","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Asad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"1","key":"4502_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"4502_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/ndt\/gfl159","volume":"21","author":"GR Bihl","year":"2006","unstructured":"Bihl GR, Petri M, Fine DM. Kidney biopsy in lupus nephritis. Nephrol Dial transplant. 2006;21(7):1749\u201352.","journal-title":"Nephrol Dial transplant"},{"issue":"8","key":"4502_CR3","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/art.38006","volume":"65","author":"CC Mok","year":"2013","unstructured":"Mok CC, Kwok RC, Yip PS. Renal disease impact in SLE mortality. Arthritis Rheum. 2013;65(8):2154\u201360.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4502_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","volume":"28","author":"A Morrison","year":"2012","unstructured":"Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: A systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28(2):138\u201344.","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"4502_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","volume":"35","author":"ST Ngo","year":"2014","unstructured":"Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347\u201369.","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"4502_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L, et al. Lupus nephritis frequency and outcomes. Rheumatology. 2016;55(2):252\u201362.","journal-title":"Rheumatology"},{"key":"4502_CR7","volume-title":"Global kidney health atlas","author":"AK Bello","year":"2017","unstructured":"Bello AK, Levin A, Tonelli M, et al. Global kidney health atlas. Brussels: ISN; 2017."},{"issue":"5","key":"4502_CR8","first-page":"524","volume":"22","author":"LJ Catoggio","year":"2013","unstructured":"Catoggio LJ, Soriano ER, Imamura PM, et al. SLE survival in Argentina. Lupus. 2013;22(5):524\u201330.","journal-title":"Lupus"},{"issue":"12","key":"4502_CR9","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1002\/art.20666","volume":"50","author":"FA Houssiau","year":"2004","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, et al. Euro-Lupus nephritis trial outcomes. Arthritis Rheum. 2004;50(12):3934\u201340.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"4502_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","volume":"383","author":"R Furie","year":"2020","unstructured":"Furie R, Rovin BH, Houssiau F, et al. Belimumab in lupus nephritis. N Engl J Med. 2020;383(12):1117\u201328.","journal-title":"N Engl J Med"},{"issue":"1","key":"4502_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12882-021-02235-y","volume":"22","author":"AD Kaze","year":"2021","unstructured":"Kaze AD, Ashuntantang G, Kengne AP, et al. LN outcomes in sub-saharan Africa. BMC Nephrol. 2021;22(1):39.","journal-title":"BMC Nephrol"},{"issue":"5993","key":"4502_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, et al. APOL1 variants in kidney disease. Science. 2010;329(5993):841\u201345.","journal-title":"Science"},{"issue":"1","key":"4502_CR13","first-page":"e000512","volume":"8","author":"P Kalilani","year":"2021","unstructured":"Kalilani P, Nyirenda T, Kamtuwanje N, et al. LN challenges in resource-limited settings. Lupus Sci Med. 2021;8(1):e000512.","journal-title":"Lupus Sci Med"},{"key":"4502_CR14","volume-title":"JBI evidence synthesis manual","author":"S Moola","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, et al. JBI evidence synthesis manual. Adelaide: JBI; 2020."},{"key":"4502_CR15","doi-asserted-by":"crossref","unstructured":"Gagnier JJ, Kienle G, Altman DG, et al. CARE case report guidelines. BMJ Case Rep. 2013, 2013;bcr2013201554.","DOI":"10.1136\/bcr-2013-201554"},{"issue":"7","key":"4502_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA-ScR guidelines. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4502_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ki.1984.75","volume":"25","author":"HA Austin 3rd","year":"1984","unstructured":"Austin HA 3rd, Muenz LR, Joyce KM, et al. Pathologic features in LN. Kidney Int. 1984;25(4):689\u201395.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04502-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04502-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04502-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:18:41Z","timestamp":1759843121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04502-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4502"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04502-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"556"}}